{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:04:07Z","timestamp":1788174247846,"version":"build-2803163510"},"reference-count":241,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"am","delay-in-days":329,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001665","name":"French National Research Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013414","name":"R\u00e9gion Pays de la Loire","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013414","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.addr.2024.115214","type":"journal-article","created":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T23:40:42Z","timestamp":1708558842000},"page":"115214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["MicroRNA-targeting nanomedicines for the treatment of intervertebral disc degeneration"],"prefix":"10.1016","volume":"207","author":[{"given":"Hussein H.","family":"Genedy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Humbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilel","family":"Laoulaou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Le Moal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Fusellier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Passirani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Le Visage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Guicheux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9lise","family":"Lepeltier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Clouet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2024.115214_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-018-0052-1","article-title":"Low back pain","volume":"4","author":"Vlaeyen","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"2023","key":"10.1016\/j.addr.2024.115214_b0010","first-page":"e316","article-title":"Low Back Pain Collaborators, Global, regional, and national burden of low back pain, 1990\u20132020, its attributable risk factors, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021","volume":"5","author":"Gbd","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.addr.2024.115214_b0015","first-page":"1","article-title":"Intervertebral disc degeneration and osteoarthritis: a common molecular disease spectrum","author":"Fine","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.addr.2024.115214_b0020","doi-asserted-by":"crossref","first-page":"e283","DOI":"10.1002\/wdev.283","article-title":"Developmental mechanisms of intervertebral disc and vertebral column formation","volume":"6","author":"Lawson","year":"2017","journal-title":"Wiley Interdiscip. Rev. Dev. Biol."},{"key":"10.1016\/j.addr.2024.115214_b0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/jdb4010003","article-title":"Notochord Cells in Intervertebral Disc Development and Degeneration","volume":"4","author":"McCann","year":"2016","journal-title":"Journal of Developmental Biology"},{"key":"10.1016\/j.addr.2024.115214_b0030","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1111\/os.13254","article-title":"Treatment of Intervertebral Disc Degeneration","volume":"14","author":"Xin","year":"2022","journal-title":"Orthop. Surg."},{"key":"10.1016\/j.addr.2024.115214_b0035","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1080\/09593985.2017.1345026","article-title":"Physiological effects of physical therapy interventions on lumbar intervertebral discs: A systematic review","volume":"33","author":"Mitchell","year":"2017","journal-title":"Physiother. Theory Pract."},{"key":"10.1016\/j.addr.2024.115214_b0040","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/00007632-200002150-00007","article-title":"Effects of Backward Bending on Lumbar Intervertebral Discs: Relevance to Physical Therapy Treatments for Low Back Pain","volume":"25","author":"Adams","year":"2000","journal-title":"Spine"},{"key":"10.1016\/j.addr.2024.115214_b0045","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3390\/reports1030021","article-title":"Long-Term Weight-Loss Lifestyle Modification Programme in a Patient with Severe Lumbar Intervertebral Disc Degeneration and Obesity: A Case Report","volume":"1","author":"El Masri","year":"2018","journal-title":"Reports"},{"key":"10.1016\/j.addr.2024.115214_b0050","doi-asserted-by":"crossref","unstructured":"C. Liu, J. Ran, B. Hou, Y. Li, J.N. Morelli, X. Li, Causal effects of body mass index, education, and lifestyle behaviors on intervertebral disc disorders: Mendelian randomization study, Journal of Orthopaedic Research n\/a (n.d.). Doi: 10.1002\/jor.25656.","DOI":"10.1002\/jor.25656"},{"key":"10.1016\/j.addr.2024.115214_b0055","first-page":"158","article-title":"Cell-based strategies for IVD repair: clinical progress and translational obstacles, Nature Reviews","volume":"17","author":"Binch","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.addr.2024.115214_b0060","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.addr.2018.04.017","article-title":"Intervertebral disc regeneration: from cell therapy to the development of novel bioinspired endogenous repair strategies","volume":"146","author":"Clouet","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2024.115214_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcell.2021.780749","article-title":"Notochordal Cell-Based Treatment Strategies and Their Potential in Intervertebral Disc Regeneration","volume":"9","author":"Bach","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.addr.2024.115214_b0070","doi-asserted-by":"crossref","first-page":"860","DOI":"10.3892\/etm.2021.10292","article-title":"Role of microRNAs in intervertebral disc degeneration (Review)","volume":"22","author":"Yang","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.addr.2024.115214_b0075","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.cca.2015.09.011","article-title":"MicroRNAs: New players in intervertebral disc degeneration","volume":"450","author":"Wang","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.addr.2024.115214_b0080","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jconrel.2019.10.007","article-title":"MicroRNA delivery through nanoparticles","volume":"313","author":"Lee","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2024.115214_b0085","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0014-5793(77)80717-5","article-title":"Nanocapsules: A new type of lysosomotropic carrier","volume":"84","author":"Couvreur","year":"1977","journal-title":"FEBS Lett."},{"key":"10.1016\/j.addr.2024.115214_b0090","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1080\/1061186X.2019.1588280","article-title":"A journey through the emergence of nanomedicines with poly(alkylcyanoacrylate) based nanoparticles","volume":"27","author":"Vauthier","year":"2019","journal-title":"J Drug Target"},{"key":"10.1016\/j.addr.2024.115214_b0095","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.addr.2024.115214_b0100","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/0142-9612(93)90004-L","article-title":"Surface modification of nanoparticles by PEO\/PPO block copolymers to minimize interactions with blood components and prolong blood circulation in rats","volume":"14","author":"Tan","year":"1993","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2024.115214_b0105","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0014-5793(90)81016-H","article-title":"Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes","volume":"268","author":"Klibanov","year":"1990","journal-title":"FEBS Lett"},{"key":"10.1016\/j.addr.2024.115214_b0110","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0168-3659(99)00248-5","article-title":"Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review","volume":"65","author":"Maeda","year":"2000","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2024.115214_b0115","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jconrel.2012.04.038","article-title":"Macromolecular therapeutics in cancer treatment: The EPR effect and beyond","volume":"164","author":"Maeda","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2024.115214_b0120","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.addr.2020.06.005","article-title":"Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancers","volume":"157","author":"Fang","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2024.115214_b0125","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.addr.2010.04.009","article-title":"The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect","volume":"63","author":"Fang","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2024.115214_b0130","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3390\/jpm11030229","article-title":"The 35th Anniversary of the Discovery of EPR Effect: A New Wave of Nanomedicines for Tumor-Targeted Drug Delivery\u2014Personal Remarks and Future Prospects","volume":"11","author":"Maeda","year":"2021","journal-title":"J Pers Med"},{"key":"10.1016\/j.addr.2024.115214_b0135","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0168-3659(99)00007-3","article-title":"Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain","volume":"59","author":"Yang","year":"1999","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2024.115214_b0140","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/BF03188928","article-title":"Drug targeting with nanoparticles","volume":"19","author":"Kreuter","year":"1994","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.addr.2024.115214_b0145","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0169-409X(98)00053-2","article-title":"Cyclodextrins in targeting: Application to nanoparticles","volume":"36","author":"Duch\u00eane","year":"1999","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2024.115214_b0150","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0168-3659(95)00164-6","article-title":"Biodegradable nanoparticles \u2014 From sustained release formulations to improved site specific drug delivery","volume":"39","author":"Leroux","year":"1996","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2024.115214_b0155","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0168-3659(97)00040-0","article-title":"Thermo-responsive polymer nanoparticles with a core-shell micelle structure as site-specific drug carriers","volume":"48","author":"Cammas","year":"1997","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2024.115214_b0160","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1006\/jcis.1998.5692","article-title":"pH- and Thermo-sensitive Hydrogel Nanoparticles","volume":"206","author":"Sahoo","year":"1998","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.addr.2024.115214_b0165","doi-asserted-by":"crossref","first-page":"e10421","DOI":"10.1002\/btm2.10421","article-title":"Micro and nanotechnologies: The little formulations that could","volume":"8","author":"Stiepel","year":"2023","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.addr.2024.115214_b0170","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","article-title":"The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14","volume":"75","author":"Lee","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.addr.2024.115214_b0175","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1177\/0300985813502820","article-title":"MicroRNAs: history, biogenesis, and their evolving role in animal development and disease","volume":"51","author":"Bhaskaran","year":"2014","journal-title":"Vet Pathol"},{"key":"10.1016\/j.addr.2024.115214_b0180","doi-asserted-by":"crossref","first-page":"D155","DOI":"10.1093\/nar\/gky1141","article-title":"miRBase: from microRNA sequences to function","volume":"47","author":"Kozomara","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.addr.2024.115214_b0185","doi-asserted-by":"crossref","first-page":"D222","DOI":"10.1093\/nar\/gkab1079","article-title":"miRTarBase update 2022: an informative resource for experimentally validated miRNA\u2013target interactions","volume":"50","author":"Huang","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.addr.2024.115214_b0190","doi-asserted-by":"crossref","first-page":"D92","DOI":"10.1093\/nar\/gkt1248","article-title":"Yang, starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein\u2013RNA interaction networks from large-scale CLIP-Seq data","volume":"42","author":"Li","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.addr.2024.115214_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114469","article-title":"Non-coding RNAs: Emerging from the discovery to therapeutic applications","volume":"189","author":"Baptista","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.addr.2024.115214_b0200","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrm.2017.104","article-title":"The functions and unique features of long intergenic non-coding RNA","volume":"19","author":"Ransohoff","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.addr.2024.115214_b0205","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2015.23","article-title":"siRNA Versus miRNA as Therapeutics for Gene Silencing","volume":"4","author":"Lam","year":"2015","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.addr.2024.115214_b0210","first-page":"1","article-title":"microRNAs in action: biogenesis, function and regulation","author":"Shang","year":"2023","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.addr.2024.115214_b0215","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1038\/s41467-021-25078-5","article-title":"The regulatory impact of RNA-binding proteins on microRNA targeting","volume":"12","author":"Kim","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.addr.2024.115214_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.101870","article-title":"RNA-binding proteins in degenerative joint diseases: A systematic review","volume":"86","author":"Xiang","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.addr.2024.115214_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115564","article-title":"MicroRNAs in cartilage development and dysplasia","volume":"140","author":"Shvedova","year":"2020","journal-title":"Bone"},{"key":"10.1016\/j.addr.2024.115214_b0230","doi-asserted-by":"crossref","first-page":"6573","DOI":"10.7150\/thno.55664","article-title":"The role of microRNAs in the osteogenic and chondrogenic differentiation of mesenchymal stem cells and bone pathologies","volume":"11","author":"Iaquinta","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.addr.2024.115214_b0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41413-022-00226-9","article-title":"Current understanding of osteoarthritis pathogenesis and relevant new approaches","volume":"10","author":"Tong","year":"2022","journal-title":"Bone Res"},{"key":"10.1016\/j.addr.2024.115214_b0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41413-023-00244-1","article-title":"Comprehensive overview of microRNA function in rheumatoid arthritis","volume":"11","author":"Peng","year":"2023","journal-title":"Bone Res"},{"key":"10.1016\/j.addr.2024.115214_b0245","article-title":"Time to retract Lancet paper on tissue engineered trachea transplants","volume":"376","author":"Schneider","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.addr.2024.115214_b0250","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/sj.embor.7400970","article-title":"How many scientific papers should be retracted?","volume":"8","author":"Cokol","year":"2007","journal-title":"EMBO Rep."},{"key":"10.1016\/j.addr.2024.115214_b0255","article-title":"The Possibility of Systematic Research Fraud Targeting Under-Studied Human Genes: Causes","volume":"14","author":"Byrne","year":"2019","journal-title":"Consequences, and Potential Solutions, Biomark Insights"},{"key":"10.1016\/j.addr.2024.115214_b0260","doi-asserted-by":"crossref","first-page":"17","DOI":"10.22203\/eCM.v039a02","article-title":"Degenerative lumbar disc disease: in vivo data support the rationale for the selection of appropriate animal models","volume":"39","author":"Fusellier","year":"2020","journal-title":"Eur. Cell. Mater."},{"key":"10.1016\/j.addr.2024.115214_b0265","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.gdata.2015.05.027","article-title":"Noncoding RNAs in human intervertebral disc degeneration: An integrated microarray study","volume":"5","author":"Liu","year":"2015","journal-title":"Genomics Data"},{"key":"10.1016\/j.addr.2024.115214_b0270","doi-asserted-by":"crossref","first-page":"63166","DOI":"10.18632\/oncotarget.11334","article-title":"Landscape of RNAs in human lumbar disc degeneration","volume":"7","author":"Lan","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.addr.2024.115214_b0275","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1038\/s41467-018-07360-1","article-title":"Preclinical development of a microRNA-based therapy for intervertebral disc degeneration","volume":"9","author":"Ji","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.addr.2024.115214_b0280","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1080\/21655979.2021.1899533","article-title":"Differentially-expressed mRNAs, microRNAs and long noncoding RNAs in intervertebral disc degeneration identified by RNA-sequencing","volume":"12","author":"Li","year":"2021","journal-title":"Bioengineered"},{"key":"10.1016\/j.addr.2024.115214_b0285","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/path.2931","article-title":"Deregulated miR-155 promotes Fas-mediated apoptosis in human intervertebral disc degeneration by targeting FADD and caspase-3","volume":"225","author":"Wang","year":"2011","journal-title":"J. Pathol."},{"key":"10.1016\/j.addr.2024.115214_b0290","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3892\/ijmm.2013.1543","article-title":"Characterization of microRNA expression profiles in patients with intervertebral disc degeneration","volume":"33","author":"Zhao","year":"2014","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.addr.2024.115214_b0295","doi-asserted-by":"crossref","first-page":"e12664","DOI":"10.1111\/cpr.12664","article-title":"miR-640 aggravates intervertebral disc degeneration via NF-\u03baB and WNT signalling pathway","volume":"52","author":"Dong","year":"2019","journal-title":"Cell Prolif"},{"key":"10.1016\/j.addr.2024.115214_b0300","doi-asserted-by":"crossref","first-page":"27868","DOI":"10.18632\/oncotarget.15838","article-title":"MicroRNA-494 promotes apoptosis and extracellular matrix degradation in degenerative human nucleus pulposus cells","volume":"8","author":"Kang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.addr.2024.115214_b0305","doi-asserted-by":"crossref","first-page":"e365","DOI":"10.1016\/j.wneu.2018.12.098","article-title":"Roles of miR-494 in Intervertebral Disk Degeneration and the Related Mechanism","volume":"124","author":"Li","year":"2019","journal-title":"World Neurosurg."},{"key":"10.1016\/j.addr.2024.115214_b0310","first-page":"3754","article-title":"CircSEMA4B targets miR-431 modulating IL-1\u03b2-induced degradative changes in nucleus pulposus cells in intervertebral disc degeneration via Wnt pathway","author":"Wang","year":"1864","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.addr.2024.115214_b0315","first-page":"1","article-title":"circ_0072464 Shuttled by Bone Mesenchymal Stem Cell-Secreted Extracellular Vesicles Inhibits Nucleus Pulposus Cell Ferroptosis to Relieve Intervertebral Disc Degeneration","volume":"2022","author":"Yu","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.addr.2024.115214_b0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13075-019-1863-5","article-title":"MicroRNA-143-5p targeting eEF2 gene mediates intervertebral disc degeneration through the AMPK signaling pathway","volume":"21","author":"Yang","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.addr.2024.115214_b0325","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1080\/15476286.2021.1898176","article-title":"MicroRNA-140-3p alleviates intervertebral disc degeneration via KLF5\/N-cadherin\/MDM2\/Slug axis","volume":"18","author":"Wang","year":"2021","journal-title":"RNA Biol."},{"key":"10.1016\/j.addr.2024.115214_b0330","doi-asserted-by":"crossref","first-page":"25401","DOI":"10.1038\/srep25401","article-title":"Matrix stiffness promotes cartilage endplate chondrocyte calcification in disc degeneration via miR-20a targeting ANKH expression","volume":"6","author":"Liu","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.addr.2024.115214_b0335","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.00147","article-title":"Silencing of Long Non-coding RNA NEAT1 Upregulates miR-195a to Attenuate Intervertebral Disk Degeneration via the BAX\/BAK Pathway","volume":"7","author":"Tang","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.addr.2024.115214_b0340","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1081185","article-title":"The potential mechanisms and application prospects of non-coding RNAs in intervertebral disc degeneration","volume":"13","author":"Jiang","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.addr.2024.115214_b0345","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1016\/j.molcel.2022.05.027","article-title":"Integrated lncRNA function upon genomic and epigenomic regulation","volume":"82","author":"Herman","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.addr.2024.115214_b0350","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/j.cell.2022.04.021","article-title":"Circular RNAs: Characterization, cellular roles, and applications","volume":"185","author":"Liu","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.addr.2024.115214_b0355","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.arr.2019.04.001","article-title":"LncRNA: Shedding light on mechanisms and opportunities in fibrosis and aging","volume":"52","author":"Yang","year":"2019","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.addr.2024.115214_b0360","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jconrel.2022.05.043","article-title":"Circular RNA: An emerging frontier in RNA therapeutic targets, RNA therapeutics, and mRNA vaccines","volume":"348","author":"Liu","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2024.115214_b0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2019.144029","article-title":"The long noncoding RNA HOTAIR serves as a microRNA-34a-5p sponge to reduce nucleus pulposus cell apoptosis via a NOTCH1-mediated mechanism","volume":"715","author":"Shao","year":"2019","journal-title":"Gene"},{"key":"10.1016\/j.addr.2024.115214_b0370","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1080\/15384101.2021.2020042","article-title":"LncRNA HOTAIR influences cell proliferation via miR-130b\/PTEN\/AKT axis in IDD","volume":"21","author":"Chen","year":"2022","journal-title":"Cell Cycle"},{"key":"10.1016\/j.addr.2024.115214_b0375","doi-asserted-by":"crossref","first-page":"4990","DOI":"10.1002\/jcb.26738","article-title":"LncRNA H19 targets miR-22 to modulate H2O2-induced deregulation in nucleus pulposus cell senescence, proliferation, and ECM synthesis through Wnt signaling","volume":"119","author":"Wang","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.addr.2024.115214_b0380","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1089\/scd.2021.0009","article-title":"LncRNA H19 Aggravates Intervertebral Disc Degeneration by Promoting the Autophagy and Apoptosis of Nucleus Pulposus Cells Through the miR-139\/CXCR4\/NF-\u03baB Axis","volume":"30","author":"Sun","year":"2021","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.addr.2024.115214_b0385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-017-0232-z","article-title":"Circular RNA GRB10 as a competitive endogenous RNA regulating nucleus pulposus cells death in degenerative intervertebral disk","volume":"9","author":"Guo","year":"2018","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.addr.2024.115214_b0390","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-020-02882-3","article-title":"The circular RNA circ-GRB10 participates in the molecular circuitry inhibiting human intervertebral disc degeneration","volume":"11","author":"Guo","year":"2020","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.addr.2024.115214_b0395","first-page":"2100596","article-title":"Extracellular Vesicles as an Emerging Treatment Option for Intervertebral Disc Degeneration: Therapeutic Potential","volume":"2100596","author":"DiStefano","year":"2021","journal-title":"Translational Pathways, and Regulatory Considerations, Advanced Healthcare Materials"},{"key":"10.1016\/j.addr.2024.115214_b0400","article-title":"Exosomes and exosomal miRNAs: A new therapy for intervertebral disc degeneration","volume":"13","author":"Li","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.addr.2024.115214_b0405","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1007\/s00018-011-0689-3","article-title":"Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles","volume":"68","author":"Gy\u00f6rgy","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.addr.2024.115214_b0410","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrm.2017.125","article-title":"Shedding light on the cell biology of extracellular vesicles","volume":"19","author":"Niel","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.addr.2024.115214_b0415","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/sctm.19-0114","article-title":"Mesenchymal stromal cell-derived extracellular vesicles for regenerative therapy and immune modulation: Progress and challenges toward clinical application","volume":"9","author":"Allan","year":"2020","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.addr.2024.115214_b0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.joca.2022.08.009","article-title":"Extracellular vesicles derived from mesenchymal stem cells confer protection against intervertebral disc degeneration through a microRNA-217-dependent mechanism","author":"Hao","year":"2022","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.addr.2024.115214_b0425","doi-asserted-by":"crossref","DOI":"10.1177\/20417314211021679","article-title":"microRNA-129-5p shuttled by mesenchymal stem cell-derived extracellular vesicles alleviates intervertebral disc degeneration via blockade of LRG1-mediated p38 MAPK activation","volume":"12","author":"Cui","year":"2021","journal-title":"J Tissue Eng"},{"key":"10.1016\/j.addr.2024.115214_b0430","article-title":"Small extracellular vesicles from hypoxic mesenchymal stem cells alleviate intervertebral disc degeneration by delivering miR-17-5p","author":"Zhou","year":"2021","journal-title":"Acta Biomater."},{"key":"10.1016\/j.addr.2024.115214_b0435","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/s13287-021-02362-1","article-title":"Induced pluripotent stem cell-derived mesenchymal stem cells deliver exogenous miR-105-5p via small extracellular vesicles to rejuvenate senescent nucleus pulposus cells and attenuate intervertebral disc degeneration","volume":"12","author":"Sun","year":"2021","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.addr.2024.115214_b0440","doi-asserted-by":"crossref","first-page":"7664","DOI":"10.3390\/ijms24087664","article-title":"Human Embryonic Stem-Cell-Derived Exosomes Repress NLRP3 Inflammasome to Alleviate Pyroptosis in Nucleus Pulposus Cells by Transmitting miR-302c","volume":"24","author":"Yu","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.addr.2024.115214_b0445","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s10020-021-00355-7","article-title":"Human umbilical cord mesenchymal stem cells deliver exogenous miR-26a-5p via exosomes to inhibit nucleus pulposus cell pyroptosis through METTL14\/NLRP3","volume":"27","author":"Yuan","year":"2021","journal-title":"Mol. Med."},{"key":"10.1016\/j.addr.2024.115214_b0450","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.omtn.2020.10.021","article-title":"Notochordal-Cell-Derived Exosomes Induced by Compressive Load Inhibit Angiogenesis via the miR-140-5p\/Wnt\/\u03b2-Catenin Axis","volume":"22","author":"Sun","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.addr.2024.115214_b0455","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.omtn.2020.07.039","article-title":"Exosome-Transported circRNA_0000253 Competitively Adsorbs MicroRNA-141-5p and Increases IDD","volume":"21","author":"Song","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.addr.2024.115214_b0460","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/s12951-023-02075-y","article-title":"Degenerated nucleus pulposus cells derived exosome carrying miR-27a-3p aggravates intervertebral disc degeneration by inducing M1 polarization of macrophages","volume":"21","author":"Zhao","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.addr.2024.115214_b0465","doi-asserted-by":"crossref","first-page":"723","DOI":"10.17219\/acem\/146968","article-title":"Increased local miR-21 expressions are linked with clinical severity in lumbar disc herniation patients with sciatic pain","volume":"31","author":"Zou","year":"2022","journal-title":"Adv. Clin. Exp. Med."},{"key":"10.1016\/j.addr.2024.115214_b0470","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.biopha.2018.01.154","article-title":"MiR-21 promotes ECM degradation through inhibiting autophagy via the PTEN\/akt\/mTOR signaling pathway in human degenerated NP cells","volume":"99","author":"Wang","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.addr.2024.115214_b0475","doi-asserted-by":"crossref","unstructured":"B. Chen, S.G. Huang, L. Ju, M. Li, F.F. Nie, Y. Zhang, Y.H. Zhang, X. Chen, F. Gao, Effect of microRNA-21 on the proliferation of human degenerated nucleus pulposus by targeting programmed cell death 4, Braz J Med Biol Res 49 (2016) e5020, S0100-879X2016000600602. Doi: 10.1590\/1414-431X20155020.","DOI":"10.1590\/1414-431x20155020"},{"key":"10.1016\/j.addr.2024.115214_b0480","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.3390\/ijms15034007","article-title":"miR-21 promotes human nucleus pulposus cell proliferation through PTEN\/AKT signaling","volume":"15","author":"Liu","year":"2014","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.addr.2024.115214_b0485","first-page":"67","article-title":"Experimental research on the effect of microRNA-21 inhibitor on a rat model of intervertebral disc degeneration","volume":"16","author":"Sheng","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.addr.2024.115214_b0490","doi-asserted-by":"crossref","first-page":"11201","DOI":"10.1080\/21655979.2021.2007697","article-title":"LncRNA OIP5-AS1 accelerates intervertebral disc degeneration by targeting miR-25-3p","volume":"12","author":"Che","year":"2021","journal-title":"Bioengineered"},{"key":"10.1016\/j.addr.2024.115214_b0495","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/mmr.2021.12363","article-title":"MicroRNA-25 protects nucleus pulposus cells against apoptosis via targeting SUMO2 in intervertebral disc degeneration","volume":"24","author":"Lei","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.addr.2024.115214_b0500","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/SHK.0000000000001947","article-title":"MECHANISM OF MIR-25-3P CARRIED BY EXTRACELLULAR VESICLES DERIVED FROM PLATELET-RICH PLASMA IN IL-1\u03b2\u2013INDUCED NUCLEUS PULPOSUS CELL DEGENERATION VIA THE SOX4\/CXCR7 AXIS","volume":"58","author":"Hu","year":"2022","journal-title":"Shock"},{"key":"10.1016\/j.addr.2024.115214_b0505","first-page":"3621","article-title":"MicroRNA-25-3p regulates human nucleus pulposus cell proliferation and apoptosis in intervertebral disc degeneration by targeting Bim","volume":"22","author":"Zhao","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.addr.2024.115214_b0510","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.21037\/atm-20-6595","article-title":"MicroRNA-25-3p therapy for intervertebral disc degeneration by targeting the IL-1\u03b2\/ZIP8\/MTF1 signaling pathway with a novel thermo-responsive vector","volume":"8","author":"Huang","year":"2020","journal-title":"Annals of Translational Medicine"},{"key":"10.1016\/j.addr.2024.115214_b0515","doi-asserted-by":"crossref","first-page":"19684","DOI":"10.1002\/jcb.29274","article-title":"Downregulation of microRNA-129-5p increases the risk of intervertebral disc degeneration by promoting the apoptosis of nucleus pulposus cells via targeting BMP2","volume":"120","author":"Yang","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.addr.2024.115214_b0520","doi-asserted-by":"crossref","first-page":"e3395","DOI":"10.1002\/jgm.3395","article-title":"EZH2 upregulates the expression of MAPK1 to promote intervertebral disc degeneration via suppression of miR-129-5p","volume":"24","author":"Zhou","year":"2022","journal-title":"J. Gene Med."},{"key":"10.1016\/j.addr.2024.115214_b0525","doi-asserted-by":"crossref","first-page":"86264","DOI":"10.18632\/oncotarget.21137","article-title":"Methylation of microRNA-129-5P modulates nucleus pulposus cell autophagy by targeting Beclin-1 in intervertebral disc degeneration","volume":"8","author":"Zhao","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.addr.2024.115214_b0530","doi-asserted-by":"crossref","first-page":"E499","DOI":"10.1097\/BRS.0000000000003322","article-title":"Circulating miR-155-5p as a Novel Biomarker of Lumbar Degenerative Disc Disease","volume":"45","author":"Divi","year":"2020","journal-title":"Spine"},{"key":"10.1016\/j.addr.2024.115214_b0535","first-page":"3239","article-title":"miRNA-155 expression and role in pathogenesis in spinal tuberculosis-induced intervertebral disc destruction","volume":"17","author":"Yang","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.addr.2024.115214_b0540","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1002\/jor.23313","article-title":"Role of miR-155 in the regulation of MMP-16 expression in intervertebral disc degeneration","volume":"35","author":"Zhang","year":"2017","journal-title":"J. Orthop. Res."},{"key":"10.1016\/j.addr.2024.115214_b0545","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.biopha.2018.09.076","article-title":"Transcription factor 7-like 2 controls matrix degradation through nuclear factor \u03baB signaling and is repressed by microRNA-155 in nucleus pulposus cells","volume":"108","author":"Sun","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.addr.2024.115214_b0550","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/03008207.2018.1483356","article-title":"MicroRNA-155 suppresses the catabolic effect induced by TNF-\u03b1 and IL-1\u03b2 by targeting C\/EBP\u03b2 in rat nucleus pulposus cells","volume":"60","author":"Zhou","year":"2019","journal-title":"Connect. Tissue Res."},{"key":"10.1016\/j.addr.2024.115214_b0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2023.110678","article-title":"MicroRNA-155 suppressed cholesterol-induced matrix degradation, pyroptosis and apoptosis by targeting ROR\u03b1 in nucleus pulposus cells","volume":"107","author":"Qin","year":"2023","journal-title":"Cell. Signal."},{"key":"10.1016\/j.addr.2024.115214_b0560","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/978-1-62703-008-3_15","article-title":"Utilizing AntagomiR (Antisense microRNA) to Knock Down microRNA in Murine Bone Marrow Cells","volume":"928","author":"Velu","year":"2012","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.addr.2024.115214_b0565","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1758-907X-3-1","article-title":"Inhibition of microRNA function by antimiR oligonucleotides","volume":"3","author":"Stenvang","year":"2012","journal-title":"Silence"},{"key":"10.1016\/j.addr.2024.115214_b0570","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.drudis.2017.09.018","article-title":"Locked nucleic acid: modality, diversity, and drug discovery","volume":"23","author":"P.H. Hagedorn, R. Persson, E.D. Funder, N. Alb\u00e6k, S.L. Diemer, D.J. Hansen, M.R. M\u00f8ller, N. Papargyri, H. Christiansen, B.R. Hansen, H.F. Hansen, M.A. Jensen, T. Koch","year":"2018","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.addr.2024.115214_b0575","doi-asserted-by":"crossref","first-page":"8504","DOI":"10.1021\/jo010732p","article-title":"A simplified and efficient route to 2\u2019-O, 4\u2019-C-methylene-linked bicyclic ribonucleosides (locked nucleic acid)","volume":"66","author":"Koshkin","year":"2001","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.addr.2024.115214_b0580","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.gene.2005.12.031","article-title":"LNA-modified oligonucleotides mediate specific inhibition of microRNA function","volume":"372","author":"\u00d8rom","year":"2006","journal-title":"Gene"},{"key":"10.1016\/j.addr.2024.115214_b0585","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/gt.2010.133","article-title":"Down-modulation of cancer targets using locked nucleic acid ({LNA})-based antisense oligonucleotides without transfection","volume":"18","author":"Zhang","year":"2011","journal-title":"Gene Ther."},{"key":"10.1016\/j.addr.2024.115214_b0590","doi-asserted-by":"crossref","DOI":"10.1093\/jmcb\/mjz047","article-title":"Functional impacts of non-coding RNA processing on enhancer activity and target gene expression","author":"Ntini","year":"2019","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.addr.2024.115214_b0595","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2017.0074","article-title":"Interplay between long non-coding RNAs and epigenetic machinery: Emerging targets in cancer?","volume":"373","author":"Hanly","year":"2018","journal-title":"Philos. Trans. R. Soc., B"},{"key":"10.1016\/j.addr.2024.115214_b0600","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.omtn.2019.08.018","article-title":"Crosstalk of mRNA, miRNA, lncRNA, and circRNA and Their Regulatory Pattern in Pulmonary Fibrosis","volume":"18","author":"Li","year":"2019","journal-title":"Molecular Therapy. Nucleic Acids"},{"key":"10.1016\/j.addr.2024.115214_b0605","first-page":"150","article-title":"Structure","volume":"11","author":"Qin","year":"2020","journal-title":"Regulation, and Function of Linear and Circular Long Non-Coding RNAs, Front Genet"},{"key":"10.1016\/j.addr.2024.115214_b0610","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/ng2079","article-title":"Target mimicry provides a new mechanism for regulation of microRNA activity","volume":"39","author":"Franco-Zorrilla","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.addr.2024.115214_b0615","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3390\/genes9090459","article-title":"Long Non-Coding RNAs as Endogenous Target Mimics and Exploration of Their Role in Low Nutrient Stress Tolerance in Plants","volume":"9","author":"Borah","year":"2018","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.addr.2024.115214_b0620","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aao2387","article-title":"MEG3-4 is a miRNA decoy that regulates IL-1 abundance to initiate and then limit inflammation to prevent sepsis during lung infection","volume":"11","author":"Li","year":"2018","journal-title":"Sci. Signal."},{"key":"10.1016\/j.addr.2024.115214_b0625","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1038\/mt.2013.113","article-title":"Managing microRNAs with vector-encoded decoy-type inhibitors","volume":"21","author":"Bak","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2024.115214_b0630","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1261\/rna.2414110","article-title":"MicroRNA sponges: Progress and possibilities","volume":"16","author":"Ebert","year":"2010","journal-title":"RNA"},{"key":"10.1016\/j.addr.2024.115214_b0635","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.01090","article-title":"Generation of MicroRNA-34 sponges and tough decoys for the heart: Developments and challenges","volume":"9","author":"Bernardo","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.addr.2024.115214_b0640","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2217\/epi-2016-0035","article-title":"Clinical development of TargomiRs, a miRNA mimic-based treatment for patients with recurrent thoracic cancer","volume":"8","author":"Reid","year":"2016","journal-title":"Epigenomics"},{"key":"10.1016\/j.addr.2024.115214_b0645","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s41544-019-0024-y","article-title":"Recent progress in microRNA-based delivery systems for the treatment of human disease","volume":"1","author":"Fu","year":"2019","journal-title":"ExRNA"},{"key":"10.1016\/j.addr.2024.115214_b0650","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.1002\/jcp.26514","article-title":"Treating cancer with microRNA replacement therapy: A literature review","volume":"233","author":"Hosseinahli","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.addr.2024.115214_b0655","doi-asserted-by":"crossref","first-page":"e41504","DOI":"10.1371\/journal.pone.0041504","article-title":"A Novel Vector-Based Method for Exclusive Overexpression of Star-Form MicroRNAs","volume":"7","author":"Qu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.addr.2024.115214_b0660","doi-asserted-by":"crossref","unstructured":"J. Fan, Y. Feng, R. Zhang, W. Zhang, Y. Shu, Z. Zeng, S. Huang, L. Zhang, B. Huang, D. Wu, B. Zhang, X. Wang, Y. Lei, Z. Ye, L. Zhao, D. Cao, L. Yang, X. Chen, B. Liu, W. Wagstaff, F. He, X. Wu, J. Zhang, J. Moriatis Wolf, M.J. Lee, R.C. Haydon, H.H. Luu, A. Huang, T.-C. He, S. Yan, A simplified system for the effective expression and delivery of functional mature microRNAs in mammalian cells, Cancer Gene Ther 27 (2020) 424\u2013437. Doi: 10.1038\/s41417-019-0113-y.","DOI":"10.1038\/s41417-019-0113-y"},{"key":"10.1016\/j.addr.2024.115214_b0665","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1021\/acs.biomac.7b01462","article-title":"Targeted, Stimuli-Responsive Delivery of Plasmid DNA and miRNAs Using a Facile Self-Assembled Supramolecular Nanoparticle System","volume":"19","author":"Wong","year":"2018","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2024.115214_b0670","doi-asserted-by":"crossref","first-page":"S244","DOI":"10.1016\/S1525-0016(16)34223-X","article-title":"614. Delivery of Micro-RNA Loaded Plasmid Through Nanoparticles Efficiently Modulate Transforming Growth Factor-Beta1 Expression in Healing Flexor Tendons: An In Vitro and In Vivo Study","volume":"23","author":"Zhou","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2024.115214_b0675","first-page":"1967","article-title":"miRNA-based therapies: Strategies and delivery platforms for oligonucleotide and non-oligonucleotide agents, Future","volume":"6","author":"Baumann","year":"2014","journal-title":"Med Chem"},{"key":"10.1016\/j.addr.2024.115214_b0680","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/mt.2012.67","article-title":"Lipid-based Nanoparticle Delivery of Pre-miR-107 Inhibits the Tumorigenicity of Head and Neck Squamous Cell Carcinoma","volume":"20","author":"Piao","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2024.115214_b0685","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.3390\/ijms21093084","article-title":"MicroRNAs-Based Nano-Strategies as New Therapeutic Approach in Multiple Myeloma to Overcome Disease Progression and Drug Resistance","volume":"21","author":"Desantis","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.addr.2024.115214_b0690","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/cpr.12180","article-title":"MicroRNA in intervertebral disc degeneration","volume":"48","author":"Li","year":"2015","journal-title":"Cell Prolif."},{"key":"10.1016\/j.addr.2024.115214_b0695","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.3390\/ijms21103601","article-title":"MicroRNAs in Intervertebral Disc Degeneration, Apoptosis, Inflammation, and Mechanobiology","volume":"21","author":"Cazzanelli","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.addr.2024.115214_b0700","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/os.13204","article-title":"The mechanism and function of miRNA in intervertebral disc degeneration","volume":"14","author":"Wang","year":"2022","journal-title":"Orthop. Surg."},{"key":"10.1016\/j.addr.2024.115214_b0705","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/jps.10286","article-title":"Barriers to Nonviral Gene Delivery","volume":"92","author":"Wiethoff","year":"2003","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2024.115214_b0710","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.tibs.2012.07.002","article-title":"MicroRNA turnover: when, how, and why","volume":"37","author":"R\u00fcegger","year":"2012","journal-title":"Trends Biochem. Sci"},{"key":"10.1016\/j.addr.2024.115214_b0715","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nrd2591","article-title":"Strategies in the design of nanoparticles for therapeutic applications","volume":"9","author":"Petros","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.addr.2024.115214_b0720","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.addr.2014.05.009","article-title":"In vivo delivery of miRNAs for cancer therapy: Challenges and strategies","volume":"81","author":"Chen","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2024.115214_b0725","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.3390\/ph15091036","article-title":"Chitosan Based MicroRNA Nanocarriers","volume":"15","author":"Genedy","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.addr.2024.115214_b0730","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.addr.2021.05.018","article-title":"Non-viral nanoparticles for RNA interference: Principles of design and practical guidelines","volume":"174","author":"Liu","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2024.115214_b0735","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemphyslip.2019.104837","article-title":"Lipid nanocarriers for microRNA delivery","volume":"226","author":"Scheideler","year":"2020","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.addr.2024.115214_b0740","doi-asserted-by":"crossref","first-page":"48651","DOI":"10.1002\/app.48651","article-title":"Polymer nanocarriers for MicroRNA delivery","volume":"137","author":"Kapadia","year":"2020","journal-title":"J. Appl. Polym. Sci."},{"key":"10.1016\/j.addr.2024.115214_b0745","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2020.101008","article-title":"Progress, challenges, and future of nanomedicine","volume":"35","author":"Zhang","year":"2020","journal-title":"Nano Today"},{"key":"10.1016\/j.addr.2024.115214_b0750","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1228160","article-title":"Harnessing the power of RNA therapeutics in treating ischemic heart failure: the TRAIN-HEART story","volume":"10","author":"Albert","year":"2024","journal-title":"Frontiers in Cardiovascular Medicine"},{"key":"10.1016\/j.addr.2024.115214_b0755","doi-asserted-by":"crossref","first-page":"723","DOI":"10.2174\/1389201017666160401145206","article-title":"Nucleic-Acid Delivery Using Lipid Nanocapsules","volume":"17","author":"Lagarce","year":"2016","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.addr.2024.115214_b0760","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1002\/anie.200703039","article-title":"Inorganic Nanoparticles as Carriers of Nucleic Acids into Cells","volume":"47","author":"Sokolova","year":"2008","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2024.115214_b0765","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.addr.2020.06.020","article-title":"Delivery of drugs, proteins, and nucleic acids using inorganic nanoparticles","volume":"156","author":"Luther","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2024.115214_b0770","doi-asserted-by":"crossref","first-page":"2212277","DOI":"10.1002\/adfm.202212277","article-title":"Metal-Organic Frameworks for Gene Therapy and Detection","volume":"33","author":"He","year":"2023","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.addr.2024.115214_b0775","first-page":"570","article-title":"FDA approves patisiran to treat hereditary transthyretin amyloidosis","volume":"14","author":"Wood","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.addr.2024.115214_b0780","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1007\/s40265-018-0983-6","article-title":"Patisiran: First Global Approval","volume":"78","author":"Hoy","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.addr.2024.115214_b0785","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/d41586-021-01222-5","article-title":"Pfizer COVID vaccine protects against worrying coronavirus variants","volume":"593","author":"Callaway","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.addr.2024.115214_b0790","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/s41565-022-01129-w","article-title":"Characterization of nanoparticles-based vaccines for COVID-19","volume":"17","author":"Guerrini","year":"2022","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.addr.2024.115214_b0795","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrg3763","article-title":"Non-viral vectors for gene-based therapy","volume":"15","author":"Yin","year":"2014","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.addr.2024.115214_b0800","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ejpb.2016.10.016","article-title":"Applications of lipid nanoparticles in gene therapy","volume":"109","author":"Del Pozo-Rodr\u00edguez","year":"2016","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.addr.2024.115214_b0805","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1039\/C5CS00700C","article-title":"Cellular processing and destinies of artificial DNA nanostructures","volume":"45","author":"Lee","year":"2016","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.addr.2024.115214_b0810","doi-asserted-by":"crossref","unstructured":"N. Boehnke, J.P. Straehla, H.C. Safford, M. Kocak, M.G. Rees, M. Ronan, D. Rosenberg, C.H. Adelmann, R.R. Chivukula, N. Nabar, A.G. Berger, N.G. Lamson, J.H. Cheah, H. Li, J.A. Roth, A.N. Koehler, P.T. Hammond, Massively parallel pooled screening reveals genomic determinants of nanoparticle delivery, Science 377 (2022) eabm5551. Doi: 10.1126\/science.abm5551.","DOI":"10.1126\/science.abm5551"},{"key":"10.1016\/j.addr.2024.115214_b0815","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.ymthe.2017.03.013","article-title":"Lipid Nanoparticle Systems for Enabling Gene Therapies","volume":"25","author":"Cullis","year":"2017","journal-title":"Mol Ther"},{"key":"10.1016\/j.addr.2024.115214_b0820","doi-asserted-by":"crossref","first-page":"30371","DOI":"10.1021\/acsami.2c06065","article-title":"Nucleic Acid-Loaded Lipid Nanoparticle Interactions with Model Endosomal Membranes","volume":"14","author":"Spadea","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.addr.2024.115214_b0825","doi-asserted-by":"crossref","unstructured":"L. Zheng, S.R. Bandara, C. Leal, Lipid nanoparticle topology regulates endosomal escape and delivery of RNA to the cytoplasm, (2022) 2022.05.20.492895. Doi: 10.1101\/2022.05.20.492895.","DOI":"10.1101\/2022.05.20.492895"},{"key":"10.1016\/j.addr.2024.115214_b0830","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ejpb.2018.05.034","article-title":"The proton sponge hypothesis: Fable or fact?","volume":"129","author":"Vermeulen","year":"2018","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.addr.2024.115214_b0835","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jconrel.2008.11.021","article-title":"Nucleic acid delivery with chitosan and its derivatives","volume":"134","author":"Lai","year":"2009","journal-title":"J Control Release"},{"key":"10.1016\/j.addr.2024.115214_b0840","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1021\/bm4000713","article-title":"Ionization behavior of chitosan and chitosan-DNA polyplexes indicate that chitosan has a similar capability to induce a proton-sponge effect as PEI","volume":"14","author":"Richard","year":"2013","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2024.115214_b0845","doi-asserted-by":"crossref","first-page":"e1452","DOI":"10.1002\/wnan.1452","article-title":"Nanoescapology: progress toward understanding the endosomal escape of polymeric nanoparticles","volume":"9","author":"Selby","year":"2017","journal-title":"WIREs Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.addr.2024.115214_b0850","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1021\/acs.bioconjchem.8b00732","article-title":"The Endosomal Escape of Nanoparticles: Toward More Efficient Cellular Delivery","volume":"30","author":"Smith","year":"2019","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.addr.2024.115214_b0855","doi-asserted-by":"crossref","first-page":"e2301337","DOI":"10.1002\/adhm.202301337","article-title":"Nucleus Pulposus-Targeting Nanocarriers Facilitate Mirna-Based Therapeutics for Intervertebral Disc Degeneration","volume":"12","author":"Chen","year":"2023","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.addr.2024.115214_b0860","doi-asserted-by":"crossref","first-page":"e2207216","DOI":"10.1002\/advs.202207216","article-title":"Polydopamine Nanoparticles Targeting Ferroptosis Mitigate Intervertebral Disc Degeneration Via Reactive Oxygen Species Depletion, Iron Ions Chelation, and GPX4 Ubiquitination Suppression","volume":"10","author":"Yang","year":"2023","journal-title":"Adv Sci (weinh)"},{"key":"10.1016\/j.addr.2024.115214_b0865","doi-asserted-by":"crossref","first-page":"e2101483","DOI":"10.1002\/adhm.202101483","article-title":"Local Delivery of Senolytic Drug Inhibits Intervertebral Disc Degeneration and Restores Intervertebral Disc Structure","volume":"11","author":"Lim","year":"2022","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.addr.2024.115214_b0870","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2011.11.031","article-title":"Local Drug Delivery Strategies for Cancer Treatment: Gels, Nanoparticles, Polymeric Films, Rods, and Wafers","volume":"159","author":"Wolinsky","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2024.115214_b0875","doi-asserted-by":"crossref","first-page":"90967","DOI":"10.1039\/C6RA17848K","article-title":"Chitosan functionalized thermosponge nano-carriers for prolonged retention and local delivery of chymopapain at the nucleus pulposus in porcine discs ex vivo","volume":"6","author":"Choi","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.addr.2024.115214_b0880","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.biotechadv.2017.11.009","article-title":"Innovative strategies for intervertebral disc regenerative medicine: From cell therapies to multiscale delivery systems","volume":"36","author":"Henry","year":"2018","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.addr.2024.115214_b0885","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.2147\/IJN.S358396","article-title":"Controlled Release of TGF-\u03b23 for Effective Local Endogenous Repair in IDD Using Rat Model","volume":"17","author":"Zhu","year":"2022","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.addr.2024.115214_b0890","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.addr.2014.10.024","article-title":"Delivery systems for the treatment of degenerated intervertebral discs","volume":"84","author":"Blanquer","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2024.115214_b0895","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jconrel.2020.08.041","article-title":"Drug delivery in intervertebral disc degeneration and osteoarthritis: Selecting the optimal platform for the delivery of disease-modifying agents","volume":"328","author":"Colella","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2024.115214_b0900","first-page":"274","article-title":"Multiple nano-drug delivery systems for intervertebral disc degeneration: Current status and future perspectives","volume":"23","author":"Liu","year":"2023","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.addr.2024.115214_b0905","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.addr.2019.08.007","article-title":"Lessons learned from intervertebral disc pathophysiology to guide rational design of sequential delivery systems for therapeutic biological factors","volume":"149\u2013150","author":"Frapin","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2024.115214_b0910","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1039\/C9TB00025A","article-title":"Injectable colloidal hydrogel with mesoporous silica nanoparticles for sustained co-release of microRNA-222 and aspirin to achieve innervated bone regeneration in rat mandibular defects","volume":"7","author":"Lei","year":"2019","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.addr.2024.115214_b0915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.22203\/eCM.v025a01","article-title":"Challenges and strategies in the repair of ruptured annulus fibrosus","volume":"25","author":"Guterl","year":"2013","journal-title":"Eur Cell Mater"},{"key":"10.1016\/j.addr.2024.115214_b0920","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s12178-008-9035-2","article-title":"Complications and pitfalls of lumbar interlaminar and transforaminal epidural injections","volume":"1","author":"Goodman","year":"2008","journal-title":"Curr Rev Musculoskelet Med"},{"key":"10.1016\/j.addr.2024.115214_b0925","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1186\/s12891-022-05970-x","article-title":"Complications of injections in conservative treatment of degenerative spine disease: a prospective unicentric study","volume":"23","author":"Voelker","year":"2022","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.addr.2024.115214_b0930","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122132","article-title":"Repair of degenerative nucleus pulposus by polyphenol nanosphere-encapsulated hydrogel gene delivery system","volume":"298","author":"Wang","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2024.115214_b0935","doi-asserted-by":"crossref","DOI":"10.1055\/s-0032-1319998","article-title":"Cell-Targeting Nanoparticles for Gene Delivery to Nucleus Pulposus Cells for Intervertebral Disk Regeneration","author":"Cunningham","year":"2012","journal-title":"Global Spine Journal 2"},{"key":"10.1016\/j.addr.2024.115214_b0940","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.actbio.2017.04.019","article-title":"Regulation of human nucleus pulposus cells by peptide-coupled substrates","volume":"55","author":"Bridgen","year":"2017","journal-title":"Acta Biomater."},{"key":"10.1016\/j.addr.2024.115214_b0945","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s13075-018-1625-9","article-title":"Short Link N promotes disc repair in a rabbit model of disc degeneration","volume":"20","author":"Mwale","year":"2018","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.addr.2024.115214_b0950","doi-asserted-by":"crossref","first-page":"36938","DOI":"10.1021\/acsami.0c10458","article-title":"Chondrocyte-Targeted MicroRNA Delivery by Engineered Exosomes toward a Cell-Free Osteoarthritis Therapy","volume":"12","author":"Liang","year":"2020","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.addr.2024.115214_b0955","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.2217\/nnm-2018-0019","article-title":"Resveratrol delivery by ultrasound-mediated nanobubbles targeting nucleus pulposus cells","volume":"13","author":"Shen","year":"2018","journal-title":"Nanomedicine"},{"key":"10.1016\/j.addr.2024.115214_b0960","doi-asserted-by":"crossref","first-page":"e1800623","DOI":"10.1002\/adhm.201800623","article-title":"Sustained and Bioresponsive Two-Stage Delivery of Therapeutic miRNA via Polyplex Micelle-Loaded Injectable Hydrogels for Inhibition of Intervertebral Disc Fibrosis","volume":"7","author":"Feng","year":"2018","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.addr.2024.115214_b0965","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1080\/10717544.2017.1340362","article-title":"Pullulan microbeads\/Si-HPMC hydrogel injectable system for the sustained delivery of GDF-5 and TGF-\u03b21: new insight into intervertebral disc regenerative medicine","volume":"24","author":"Henry","year":"2017","journal-title":"Drug Deliv."},{"key":"10.1016\/j.addr.2024.115214_b0970","doi-asserted-by":"crossref","first-page":"2206888","DOI":"10.1002\/smll.202206888","article-title":"Extracellular Vesicle-Conjugated Functional Matrix Hydrogels Prevent Senescence by Exosomal miR-3594-5p-Targeted HIPK2\/p53 Pathway for Disc Regeneration","volume":"19","author":"Peng","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.addr.2024.115214_b0975","doi-asserted-by":"crossref","first-page":"1902099","DOI":"10.1002\/advs.201902099","article-title":"Gene-Hydrogel Microenvironment Regulates Extracellular Matrix Metabolism Balance in Nucleus Pulposus","volume":"7","author":"Chen","year":"2020","journal-title":"Adv. Sci."},{"key":"10.1016\/j.addr.2024.115214_b0980","doi-asserted-by":"crossref","DOI":"10.1021\/acsnano.2c11441","article-title":"Development of a Nanohybrid Peptide Hydrogel for Enhanced Intervertebral Disc Repair and Regeneration","author":"Conley","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2024.115214_b0985","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.spinee.2018.10.016","article-title":"Efficiency of dual siRNA-mediated gene therapy for intervertebral disc degeneration (IVDD)","volume":"19","author":"Banala","year":"2019","journal-title":"Spine J."},{"key":"10.1016\/j.addr.2024.115214_b0990","article-title":"PLGA-based dual targeted nanoparticles enhance miRNA transfection efficiency in hepatic carcinoma","volume":"7","author":"Cai","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2024.115214_b0995","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1166\/mex.2022.2215","article-title":"Polystyrene nanoparticles carrying miR-375 alleviate inflammatory response of intervertebral disc nucleus pulposus cells via NF-\u03baB signaling pathway","volume":"12","author":"Zhang","year":"2022","journal-title":"Mater. Express"},{"key":"10.1016\/j.addr.2024.115214_b1000","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3390\/jfb14020052","article-title":"Novel Injectable Fluorescent Polymeric Nanocarriers for Intervertebral Disc Application","volume":"14","author":"Arul","year":"2023","journal-title":"J. Func. Biomater."},{"key":"10.1016\/j.addr.2024.115214_b1005","doi-asserted-by":"crossref","first-page":"8214","DOI":"10.1007\/s12274-022-4285-7","article-title":"Co-delivery of luteolin and TGF-\u03b21 plasmids with ROS-responsive virus-inspired nanoparticles for microenvironment regulation and chemo-gene therapy of intervertebral disc degeneration","volume":"15","author":"Ding","year":"2022","journal-title":"Nano Res."},{"key":"10.1016\/j.addr.2024.115214_b1010","first-page":"897","article-title":"Nanocellulose reinforced gellan-gum hydrogels as potential biological substitutes for annulus fibrosus tissue regeneration, Nanomed.-Nanotechnol","volume":"14","author":"Pereira","year":"2018","journal-title":"Biol. Med."},{"key":"10.1016\/j.addr.2024.115214_b1015","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12951-023-01856-9","article-title":"Isoginkgetin-loaded reactive oxygen species scavenging nanoparticles ameliorate intervertebral disc degeneration via enhancing autophagy in nucleus pulposus cells","volume":"21","author":"Yu","year":"2023","journal-title":"J Nanobiotechnology"},{"key":"10.1016\/j.addr.2024.115214_b1020","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.actbio.2016.06.013","article-title":"Anti-inflammatory Chitosan\/Poly-\u03b3-glutamic acid nanoparticles control inflammation while remodeling extracellular matrix in degenerated intervertebral disc","volume":"42","author":"Teixeira","year":"2016","journal-title":"Acta Biomater"},{"key":"10.1016\/j.addr.2024.115214_b1025","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s10856-016-5787-1","article-title":"Poly(\u03b3-glutamic acid) and poly(\u03b3-glutamic acid)-based nanocomplexes enhance type II collagen production in intervertebral disc","volume":"28","author":"Antunes","year":"2017","journal-title":"J Mater Sci Mater Med"},{"key":"10.1016\/j.addr.2024.115214_b1030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121941","article-title":"Lipid nanocapsules for intracellular delivery of microRNA: A first step towards intervertebral disc degeneration therapy","volume":"624","author":"Le Moal","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2024.115214_b1035","doi-asserted-by":"crossref","first-page":"921","DOI":"10.2147\/DDDT.S242493","article-title":"Oxymatrine Liposomes for Intervertebral Disc Treatment: Formulation, in vitro and vivo Assessments","volume":"14","author":"Wang","year":"2020","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.addr.2024.115214_b1040","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12951-023-01789-3","article-title":"Magnetofection of miR-21 promoted by electromagnetic field and iron oxide nanoparticles via the p38 MAPK pathway contributes to osteogenesis and angiogenesis for intervertebral fusion","volume":"21","author":"Wang","year":"2023","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.addr.2024.115214_b1045","doi-asserted-by":"crossref","first-page":"e2105466","DOI":"10.1002\/advs.202105466","article-title":"Prussian Blue Nanoparticles Stabilize SOD1 from Ubiquitination-Proteasome Degradation to Rescue Intervertebral Disc Degeneration","volume":"9","author":"Zhou","year":"2022","journal-title":"Adv Sci (weinh)"},{"key":"10.1016\/j.addr.2024.115214_b1050","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1021\/acsabm.2c00269","article-title":"Amine Functionalized Trimetallic Nitride Endohedral Fullerenes: A Class of Nanoparticle to Tackle Low Back\/Leg Pain","volume":"5","author":"Xiao","year":"2022","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.addr.2024.115214_b1055","doi-asserted-by":"crossref","first-page":"4612","DOI":"10.1007\/s11837-022-05486-8","article-title":"Mesoporous Silica Nano-Particles Based Arctigenin (MSN-ARC-G) Attenuates Intervertebral Disc Degeneration (IVDD) and Inflammation in Mice and Human NP Cells by Suppressing the MAPK\/ERK Pathway","volume":"74","author":"Wang","year":"2022","journal-title":"JOM"},{"key":"10.1016\/j.addr.2024.115214_b1060","doi-asserted-by":"crossref","first-page":"38405","DOI":"10.1021\/acsami.9b11783","article-title":"A New Formyl Peptide Receptor-1 Antagonist Conjugated Fullerene Nanoparticle for Targeted Treatment of Degenerative Disc Diseases","volume":"11","author":"Xiao","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.addr.2024.115214_b1065","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1021\/acsbiomaterials.7b00735","article-title":"Hydroxylated Fullerene: A Stellar Nanomedicine to Treat Lumbar Radiculopathy via Antagonizing TNF-\u03b1-lnduced Ion Channel Activation, Calcium Signaling, and Neuropeptide Production","volume":"4","author":"Xiao","year":"2018","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.addr.2024.115214_b1070","first-page":"2049","article-title":"Nanoparticle fullerol alleviates radiculopathy via NLRP3 inflammasome and neuropeptides, Nanomed.-Nanotechnol","volume":"13","author":"Jin","year":"2017","journal-title":"Biol. Med."},{"key":"10.1016\/j.addr.2024.115214_b1075","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1042\/CBI20090382","article-title":"Transcriptional alteration of matrix-related gene expression in cultured human disc cells by nanoparticles of a bismethanophosphonate fullerene","volume":"34","author":"Yang","year":"2010","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.addr.2024.115214_b1080","doi-asserted-by":"crossref","unstructured":"H. Zhou, Q. Qian, Q. Chen, T. Chen, C. Wu, L. Chen, Z. Zhang, O. Wu, Y. Jin, X. Wang, Z. Guo, J. Sun, J. Zhang, S. Shen, X. Wang, M. Jones, M.A. Khan, P. Makvandi, Y. Zhou, A. Wu, Enhanced Mitochondrial Targeting and Inhibition of Pyroptosis with Multifunctional Metallopolyphenol Nanoparticles in Intervertebral Disc Degeneration, Small n\/a (n.d.) 2308167. Doi: 10.1002\/smll.202308167.","DOI":"10.1002\/smll.202308167"},{"key":"10.1016\/j.addr.2024.115214_b1085","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.spinee.2013.04.004","article-title":"Fullerol nanoparticles suppress inflammatory response and adipogenesis of vertebral bone marrow stromal cells-a potential novel treatment for intervertebral disc degeneration","volume":"13","author":"Liu","year":"2013","journal-title":"Spine Journal"},{"key":"10.1016\/j.addr.2024.115214_b1090","first-page":"107","article-title":"Engineered high-strength biohydrogel as a multifunctional platform to deliver nucleic acid for ameliorating intervertebral disc degeneration","volume":"25","author":"Chen","year":"2023","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.addr.2024.115214_b1095","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2022.101462","article-title":"Identification of inflammatory regulation roles of thalidomide\/ruxolitinib in nucleus pulposus and construction of polyelectrolyte nanocomplexes- impregnated injectable hydrogels for synergistic intervertebral disk degeneration treatment","volume":"44","author":"Hu","year":"2022","journal-title":"Nano Today"},{"key":"10.1016\/j.addr.2024.115214_b1100","first-page":"551","article-title":"Injectable bioorthogonal hydrogel (BIOGEL) accelerates tissue regeneration in degenerated intervertebral discs","volume":"23","author":"Luo","year":"2023","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.addr.2024.115214_b1105","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/35888","article-title":"Potent and specific genetic interference by double-stranded RNA in caenorhabditis elegans","volume":"391","author":"Fire","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.addr.2024.115214_b1110","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat Rev Mater"},{"key":"10.1016\/j.addr.2024.115214_b1115","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2012.06.002","article-title":"Improvement of drug safety by the use of lipid-based nanocarriers","volume":"163","author":"Lim","year":"2012","journal-title":"J Control Release"},{"key":"10.1016\/j.addr.2024.115214_b1120","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ejpb.2016.08.001","article-title":"Preclinical safety of solid lipid nanoparticles and nanostructured lipid carriers: Current evidence from in vitro and in vivo evaluation","volume":"108","author":"Doktorovov\u00e1","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2024.115214_b1125","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/polym3031377","article-title":"Poly Lactic-co-Glycolic Acid (PLGA) as biodegradable controlled drug delivery carrier","volume":"3","author":"Makadia","year":"2011","journal-title":"Polymers"},{"key":"10.1016\/j.addr.2024.115214_b1130","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jconrel.2018.09.017","article-title":"PLGA polymer: From a classic drug carrier to a novel therapeutic activity contributor","volume":"289","author":"Chereddy","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2024.115214_b1135","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.spinee.2020.10.004","article-title":"Allogeneic mesenchymal precursor cells treatment for chronic low back pain associated with degenerative disc disease: a prospective randomized, placebo-controlled 36-month study of safety and efficacy","volume":"21","author":"Amirdelfan","year":"2021","journal-title":"Spine J."},{"key":"10.1016\/j.addr.2024.115214_b1140","doi-asserted-by":"crossref","first-page":"e9563693","DOI":"10.1155\/2022\/9563693","article-title":"Intradiscal Autologous Platelet-Rich Plasma Injection for Discogenic Low Back Pain: A Clinical Trial","volume":"2022","author":"Zhang","year":"2022","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.addr.2024.115214_b1145","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jos.2015.10.005","article-title":"Single intradiscal injection of the interleukin-6 receptor antibody tocilizumab provides short-term relief of discogenic low back pain; prospective comparative cohort study","volume":"21","author":"Sainoh","year":"2016","journal-title":"J. Orthop. Sci."},{"key":"10.1016\/j.addr.2024.115214_b1150","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/s12951-021-00991-5","article-title":"Injectable exosome-functionalized extracellular matrix hydrogel for metabolism balance and pyroptosis regulation in intervertebral disc degeneration","volume":"19","author":"Xing","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.addr.2024.115214_b1155","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1286223","article-title":"Application and development of hydrogel biomaterials for the treatment of intervertebral disc degeneration: a literature review","volume":"11","author":"Liu","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.addr.2024.115214_b1160","unstructured":"DISCODOG clinical research protocol, (n.d.). https:\/\/chuv.oniris-nantes.fr\/animaux-de-compagnie\/imagerie-medicale\/protocole-de-recherche-clinique-discodog\/ (accessed February 9, 2024)."},{"key":"10.1016\/j.addr.2024.115214_b1165","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1039\/D3NA00484H","article-title":"Navigating the challenges of lipid nanoparticle formulation: the role of unpegylated lipid surfactants in enhancing drug loading and stability","volume":"6","author":"Hogarth","year":"2024","journal-title":"Nanoscale Adv"},{"key":"10.1016\/j.addr.2024.115214_b1170","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1039\/D3LC00520H","article-title":"3D-printed microfluidic device for high-throughput production of lipid nanoparticles incorporating SARS-CoV-2 spike protein mRNA","volume":"24","author":"Lin","year":"2024","journal-title":"Lab Chip"},{"key":"10.1016\/j.addr.2024.115214_b1175","article-title":"Microfluidic generation of diverse lipid nanoparticle libraries","author":"Hanna","year":"2024","journal-title":"Nanomedicine (lond)"},{"key":"10.1016\/j.addr.2024.115214_b1180","doi-asserted-by":"crossref","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","article-title":"Lipid Nanoparticles\u2500From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement","volume":"15","author":"Tenchov","year":"2021","journal-title":"ACS Nano"},{"issue":"24","key":"10.1016\/j.addr.2024.115214_b1185","first-page":"00050","article-title":"Quality assessment of LNP-RNA therapeutics with orthogonal analytical techniques","volume":"S0168\u20133659","author":"Parot","year":"2024","journal-title":"J Control Release"},{"key":"10.1016\/j.addr.2024.115214_b1190","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jcis.2023.12.165","article-title":"Evolution of the structure of lipid nanoparticles for nucleic acid delivery: From in situ studies of formulation to colloidal stability","volume":"660","author":"Gilbert","year":"2024","journal-title":"J Colloid Interface Sci"},{"key":"10.1016\/j.addr.2024.115214_b1195","doi-asserted-by":"crossref","DOI":"10.1038\/s41573-023-00859-3","article-title":"Strategies to reduce the risks of mRNA drug and vaccine toxicity","author":"Bitounis","year":"2024","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.addr.2024.115214_b1200","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1038\/s41598-024-52685-1","article-title":"A careful look at lipid nanoparticle characterization: analysis of benchmark formulations for encapsulation of RNA cargo size gradient","volume":"14","author":"Schober","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.addr.2024.115214_b1205","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3390\/pharmaceutics16010131","article-title":"Chemistry and Art of Developing Lipid Nanoparticles for Biologics Delivery: Focus on Development and Scale-Up","volume":"16","author":"John","year":"2024","journal-title":"Pharmaceutics"}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X2400036X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X2400036X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T05:47:17Z","timestamp":1759211237000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X2400036X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":241,"alternative-id":["S0169409X2400036X"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2024.115214","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MicroRNA-targeting nanomedicines for the treatment of intervertebral disc degeneration","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2024.115214","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115214"}}